Clinical and Laboratory Findings in Patients with δ-Storage Pool Disease: A Case Series

Fabien Selle1, Chloé James1, Marie Tuffigo1

  • 1Université de Bordeaux, Bordeaux, France.

Insights

Platelet δ-storage pool disease (δ-SPD) is a rare platelet disorder affecting dense granules. This study reveals GPIb-impaired mobilization as a potential additional feature, complicating diagnosis.

Area of Science:

  • Hematology
  • Platelet Physiology
  • Genetic Blood Disorders

Background:

  • Platelet δ-storage pool disease (δ-SPD) is characterized by deficient dense granules, impacting platelet function.
  • Existing literature primarily consists of case reports, limiting comprehensive understanding of δ-SPD.
  • This study retrospectively analyzes a cohort of 16 patients to better define δ-SPD characteristics.

Observation:

  • Patients presented with mild to moderate bleeding diathesis.
  • Platelet aggregation showed variable abnormalities, with a consistent near-complete absence of ATP release.
  • Dense granule content and ultrastructure varied, allowing for subtype classification (quantitative vs. qualitative defects).

Findings:

  • Dense granule deficiency is the hallmark of δ-SPD.
  • Subtypes of δ-SPD can be distinguished by quantitative or qualitative dense granule defects.
  • A novel finding is significantly decreased GPIb expression upon activation, suggesting impaired GPIb mobilization.

Implications:

  • δ-SPD is a complex disorder with diverse clinical and biological manifestations.
  • Impaired GPIb mobilization may be an underrecognized aspect of δ-SPD.
  • Accurate diagnosis of δ-SPD requires specialized expertise and comprehensive testing.

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
897
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
422
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
248
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
389
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
947
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
430